Climb Bio, Inc. (CLYM)
9.22
-0.06
(-0.65%)
USD |
NASDAQ |
Nov 20, 15:17
Climb Bio 30-Day Average Daily Volume : 1.155M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 1.155M |
| November 18, 2026 | 1.174M |
| November 17, 2026 | 1.170M |
| November 16, 2026 | 1.182M |
| November 13, 2026 | 1.200M |
| November 12, 2026 | 1.230M |
| November 11, 2026 | 1.217M |
| November 10, 2026 | 1.208M |
| November 09, 2026 | 1.194M |
| November 06, 2026 | 1.162M |
| November 05, 2026 | 1.175M |
| November 04, 2026 | 1.189M |
| November 03, 2026 | 1.226M |
| November 02, 2026 | 1.227M |
| October 30, 2026 | 1.230M |
| October 29, 2026 | 1.341M |
| October 28, 2026 | 1.365M |
| October 27, 2026 | 1.421M |
| October 26, 2026 | 1.342M |
| October 23, 2026 | 1.266M |
| October 22, 2026 | 1.296M |
| October 21, 2026 | 1.324M |
| October 20, 2026 | 1.347M |
| October 19, 2026 | 1.332M |
| October 16, 2026 | 1.341M |
| Date | Value |
|---|---|
| October 15, 2026 | 1.493M |
| October 14, 2026 | 1.549M |
| October 13, 2026 | 1.582M |
| October 12, 2026 | 1.60M |
| October 09, 2026 | 1.598M |
| October 08, 2026 | 1.628M |
| October 07, 2026 | 1.636M |
| October 06, 2026 | 1.651M |
| October 05, 2026 | 1.659M |
| October 02, 2026 | 1.651M |
| October 01, 2026 | 1.628M |
| September 30, 2026 | 1.639M |
| September 29, 2026 | 1.631M |
| September 28, 2026 | 1.655M |
| September 25, 2026 | 1.711M |
| September 24, 2026 | 1.713M |
| September 23, 2026 | 1.694M |
| September 22, 2026 | 1.647M |
| September 21, 2026 | 1.642M |
| September 18, 2026 | 1.631M |
| September 17, 2026 | 1.544M |
| September 16, 2026 | 1.534M |
| September 15, 2026 | 1.481M |
| September 14, 2026 | 1.457M |
| September 11, 2026 | 1.443M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Korsana Biosciences, Inc. | 181985.4 |
| Cullinan Therapeutics, Inc. | 873129.0 |
| Q32 Bio, Inc. | 448873.3 |
| Oncolytics Biotech, Inc. | 1.369M |
| Sangamo Therapeutics, Inc. | 1.137M |